ASM launches PE2O8 silicon carbide epitaxy system

Udgivet den 30-09-2024  |  kl. 18:00  |  

Raleigh, NC, USA
September 30, 2024

New system extends ASM's portfolio of industry benchmark single wafer silicon carbide epitaxy systems, the 6" PE1O6 and 8" PE1O8 systems, with a higher throughput, lower cost of ownership, dual chamber, single wafer, 6" and 8" compatible, silicon carbide epitaxy system.

Today at the 2024 International Conference on Silicon Carbide and Related Materials, ASM International N.V. (Euronext Amsterdam: ASM) introduced the PE2O8 silicon carbide epitaxy system, a new, dual chamber, platform for silicon carbide (SiC) epitaxy (Epi). Designed to address the needs of the advanced SiC power device segment, the PE2O8 is the benchmark epitaxy system for low defectivity, high process uniformity, all with higher throughput and low cost of ownership needed to enable broader adoption of SiC devices.

As the general electrification trend drives more power device manufacturers to utilize SiC for a growing number of high-power applications (such as for electric vehicles, green power, and advanced data centers) the expanded demand and requirements for lower cost for SiC is causing a transition from 6" to 8" SiC substrates. At the same time, SiC device manufacturers are designing higher power devices that will benefit from better SiC epitaxy.

Utilizing a unique design, the dual chamber PE2O8 system deposits SiC with ultra precise control, enabling benchmark higher yield and higher throughput. The highly compact, dual chamber design enables high productivity and low total costs of operation. Additionally, the system features an easy preventive maintenance approach helping to increase uptime and reduce the occurrence of unscheduled downtime. System deliveries have been ongoing to multiple customers globally, among them leaders in SiC power device manufacturing.

"We are at a critical inflection for silicon carbide power products, as our customers transition from 6" to 8" wafers", said Steven Reiter, Corporate Vice President, and business unit head of Plasma and Epi at ASM. "Delivering a high-quality epitaxy process on larger wafers with defectivity control is critical, and we have been the industry benchmark for process uniformity with our novel chamber design. We have now extended our system capability to improve our process control and our value for customers with lower cost of ownership."

Since 2022, ASM, through its new SiC Epi product unit has been developing and refining its single wafer SiC epitaxy system. With the structurally higher demand for electric vehicles and improvement of the overall SiC wafer and device yield, the equipment market for SiC epitaxy has grown substantially in recent years.  

About ASM International

ASM International N.V., headquartered in Almere, the Netherlands, and its subsidiaries design and manufacture equipment and process solutions to produce semiconductor devices for wafer processing, and have facilities in the United States, Europe, and Asia. ASM International's common stock trades on the Euronext Amsterdam Stock Exchange (symbol: ASM). For more information, visit ASM's website at www.asm.com.

Contact

Investor and media relations

Victor Bareño
T: +31 88 100 8500
E: investor.relations@asm.com
 

Investor relations

Valentina Fantigrossi
T: +31 88 100 8502
E: investor.relations@asm.com

Attachment

20240930 ASM launches PE2O8 silicon carbide epitaxy system

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

06:30 Kalender med link - mandag den 18. november
17:46 Europa/lukning: RFK som USA's sundhedsminister var gift for medicinalaktierne
17:07 Fredagens aktier: Nedtur til medicinalaktierne trak C25 i laveste niveau i år
17:00 Fredagens obligationer: Renten hoppede på stedet trods stærke tal fra USA
15:52 Forventninger dæmpes: Nu kun "fifty-fifty" om Fed sænker renten i december
15:39 USA/åbning: Kommentar fra Powell om renteudsigterne presser aktierne
15:08 Tørlastindekset Baltic Dry stiger for ottende gang på ni dage
14:00 USA/tendens: Powells rolige rentetilgang sender futures i rødt
13:55 DFDS-aktien i vejret efter alligevel at være kommet i mål med tyrkisk opkøb
13:16 Europa/aktier: Valg af vaccineskeptiker som USA's sundhedsminister tynger medicinal
13:14 DFDS køber alligevel tyrkisk virksomhed men på nye betingelser
13:07 SP Groups markante indtjeningsfremgang drevet af øget salg af egne varemærker
12:55 Trumps udnævnelse af kontroversiel sundhedsminister lægger pres på danske medicinalaktier
12:01 Obligationer/middag: Renten går et nøk ned inden amerikansk detailsalg
11:54 Aktier/middag: Bavarian får klø efter regnskab og kontroversielt ministervalg i USA
11:24 Efter en periode på sidelinjen anbefaler Danske Bank igen køb af NKT-aktien
11:12 Vi har rykket en del af julegaveindkøbene til andet kvartal siger MAtas-topchef
10:34 Bavarian Nordic løfter lidt af sløret for 2025: Har hentet ordrer for 2,4 mia. kr.
10:07 Topchef i Matas om omsætningsvækst: Flere nye varer, striber i Norden og hurtig levering
09:22 Bavarian dykker på bekymringer om 2025 og USA's nye sundhedsminister